In a welcome move, Moody's saw its Relative Strength Rating rise from 69 to 74 on Tuesday.
IBD's proprietary rating tracks market leadership with a 1 (worst) to 99 (best) score. The rating shows how a stock's price performance over the last 52 weeks compares to all the other stocks in our database.
Over 100 years of market history shows that the stocks that go on to make the biggest gains typically have an RS Rating north of 80 in the early stages of their moves. See if Moody's can continue to rebound and clear that threshold.
Can You Really Time The Stock Market?
Moody's is trying to complete a consolidation with a 531.93 buy point. See if it can clear the breakout price in volume at least 40% higher than normal.
The company reported 20% earnings growth in its most recent report. Sales rose 13%. Look for the next report on or around Apr. 22.
The company earns the No. 5 rank among its peers in the Commercial Services-Market Research industry group. Verisk Analytics is the top-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Which Stocks Are Showing Improved Technical Action?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
